Linked Life Data

10484947

Source:http://linkedlifedata.com/resource/pubmed/id/10484947

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1999-9-27
pubmed:abstractText
The purpose of this study was to evaluate the clinical safety and efficacy of risperidone compared to haloperidol in patients with treatment-refractory schizophrenia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0002-953X
pubmed:author
pubmed:issnType
Print
pubmed:volume
156
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1374-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10484947-Adult, pubmed-meshheading:10484947-Antipsychotic Agents, pubmed-meshheading:10484947-Basal Ganglia Diseases, pubmed-meshheading:10484947-Brief Psychiatric Rating Scale, pubmed-meshheading:10484947-Cholinergic Antagonists, pubmed-meshheading:10484947-Double-Blind Method, pubmed-meshheading:10484947-Drug Administration Schedule, pubmed-meshheading:10484947-Dyskinesia, Drug-Induced, pubmed-meshheading:10484947-Female, pubmed-meshheading:10484947-Haloperidol, pubmed-meshheading:10484947-Humans, pubmed-meshheading:10484947-Male, pubmed-meshheading:10484947-Placebos, pubmed-meshheading:10484947-Psychiatric Status Rating Scales, pubmed-meshheading:10484947-Risperidone, pubmed-meshheading:10484947-Schizophrenia, pubmed-meshheading:10484947-Schizophrenic Psychology, pubmed-meshheading:10484947-Severity of Illness Index, pubmed-meshheading:10484947-Treatment Outcome
pubmed:year
1999
pubmed:articleTitle
Risperidone in treatment-refractory schizophrenia.
pubmed:affiliation
Department of Psychiatry, VA Greater Los Angeles Healthcare System, CA 90073, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't